New multifunctional propargylamines were synthesized and evaluated biologically. All compounds selectively inhibit human butyrylcholinesterase. All compounds cross the blood-brain barrier in an in vitro assay. Three compounds also inhibit monamine oxidase B. The crystal structure of human butyrylcholinesterase in complex with 3 was solved.